Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Learn about Canada’s 2026 monograph updates for primary and secondary sunscreens and acne products, and understand the practical implications for compliance and product authorization.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
ECHA is enhancing its oversight on animal testing, requiring companies to use it only as a last resort and to propose alternatives. A consultation with stakeholders is underway to implement these measures, aligning with the European Ombudsman's recommendations.
Navigating the complexities of biocidal product marketing requires a reliable provider to streamline regulatory processes, manage costs, and ensure compliance with EU regulations. Key steps include setting specifications, evaluating providers, and leveraging expert support for strategic and cost-effective solutions.
The Biocides Regulation 528/2012 (BPR) brings you to change your approaches from manufacturing to marketing your product. Many parameters must be taken into account and it can be difficult to navigate. EcoMundo gives you the keys to select a provider to help you to comply.
ECHA's report highlights a growing trend in using alternatives to animal testing for chemical toxicity, with increased implementation of read-across and in vitro methods. This aligns with REACH's goals and is notably advancing in Vietnam with government support.
The Biocidal Products Regulations (BPR) EU No. 528/2012, effective from September 2013, replaced the French Directive No. 98/8 EC. It introduces new provisions like data sharing and Union authorization, aiming to enhance human and environmental protection and simplify marketing authorization.
This guide offers technical advice on BPR obligations for active microorganisms and biocidal products, covering identification, effectiveness, and impact on humans, animals, and the environment. It replaces previous guidance documents, aligning with Annex II and III of the BPR.